354 related articles for article (PubMed ID: 15934858)
1. Pharmacotherapy of erectile dysfunction: focus on cardiovascular safety.
Reffelmann T; Kloner RA
Expert Opin Drug Saf; 2005 May; 4(3):531-40. PubMed ID: 15934858
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective.
Jackson G; Montorsi P; Cheitlin MD
Urology; 2006 Sep; 68(3 Suppl):47-60. PubMed ID: 17011375
[TBL] [Abstract][Full Text] [Related]
3. Emerging oral drugs for erectile dysfunction.
Briganti A; Salonia A; Gallina A; Suardi N; Rigatti P; Montorsi F
Expert Opin Emerg Drugs; 2004 May; 9(1):179-89. PubMed ID: 15155143
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular safety of PDE5 inhibitors.
Herschorn S
Can J Urol; 2003 Feb; 10 Suppl 1():23-8. PubMed ID: 12625847
[TBL] [Abstract][Full Text] [Related]
5. [Sex, erectile dysfunction, and the heart: a growing problem].
Görge G; Flüchter S; Kirstein M; Kunz T
Herz; 2003 Jun; 28(4):284-90. PubMed ID: 12825143
[TBL] [Abstract][Full Text] [Related]
6. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).
Kostis JB; Jackson G; Rosen R; Barrett-Connor E; Billups K; Burnett AL; Carson C; Cheitlin M; Debusk R; Fonseca V; Ganz P; Goldstein I; Guay A; Hatzichristou D; Hollander JE; Hutter A; Katz S; Kloner RA; Mittleman M; Montorsi F; Montorsi P; Nehra A; Sadovsky R; Shabsigh R
Am J Cardiol; 2005 Jul; 96(2):313-21. PubMed ID: 16018863
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
Kloner RA
Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
[TBL] [Abstract][Full Text] [Related]
8. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
[TBL] [Abstract][Full Text] [Related]
9. Managing sexual dysfunction. Using sildenafil for patients with cardiovascular disease. Heart and Stroke Foundation of Canada. Canadian Cardiovascular Society.
Can Fam Physician; 2000 Feb; 46():393, 398. PubMed ID: 10690496
[No Abstract] [Full Text] [Related]
10. Erectile dysfunction, sildenafil and cardiovascular risk.
Chew KK; Stuckey BG; Thompson PL
Med J Aust; 2000 Mar; 172(6):279-83. PubMed ID: 10860094
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
12. Erectile dysfunction in patients with coronary artery disease.
Kloner R; Padma-Nathan H
Int J Impot Res; 2005; 17(3):209-15. PubMed ID: 15729374
[TBL] [Abstract][Full Text] [Related]
13. Update on oral treatments for male erectile dysfunction.
Kalsi JS; Kell PD
J Eur Acad Dermatol Venereol; 2004 May; 18(3):267-74. PubMed ID: 15096134
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 5 inhibitors for erectile dysfunction.
Setter SM; Iltz JL; Fincham JE; Campbell RK; Baker DE
Ann Pharmacother; 2005; 39(7-8):1286-95. PubMed ID: 15941818
[TBL] [Abstract][Full Text] [Related]
15. [Hypertension and impotence. Which potency drug is the most appropriate here?].
Köhn FM
MMW Fortschr Med; 2002 Mar; 144(10):12-3. PubMed ID: 11928255
[No Abstract] [Full Text] [Related]
16. [Update of PDE5 inhibitors as treatment of ED].
Lu YN; Chen B
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):552-5. PubMed ID: 16078679
[TBL] [Abstract][Full Text] [Related]
17. [Sildenafil--adverse effects, complications and safety].
Sperling H; Michel MC
Wien Klin Wochenschr; 2002 Jan; 114(1-2):4-6. PubMed ID: 12407928
[No Abstract] [Full Text] [Related]
18. Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.
Kloner RA
Circulation; 2004 Nov; 110(19):3149-55. PubMed ID: 15533876
[No Abstract] [Full Text] [Related]
19. Appropriate use of exercise testing prior to administration of drugs for treatment of erectile dysfunction.
Arruda-Olson AM; Pellikka PA
Herz; 2003 Jun; 28(4):291-7. PubMed ID: 12825144
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of sildenafil citrate.
Umrani DN; Goyal RK
Indian J Physiol Pharmacol; 1999 Apr; 43(2):160-4. PubMed ID: 10365306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
